These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 26390847

  • 21. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB, Kong X, Niver BE, Berkman DS, Melamed J, Babb JS, Taneja SS.
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [Abstract] [Full Text] [Related]

  • 22. Introducing parametric fusion PET/MRI of primary prostate cancer.
    Park H, Wood D, Hussain H, Meyer CR, Shah RB, Johnson TD, Chenevert T, Piert M.
    J Nucl Med; 2012 Apr; 53(4):546-51. PubMed ID: 22419751
    [Abstract] [Full Text] [Related]

  • 23. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [Abstract] [Full Text] [Related]

  • 24. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M, Tatsumi M, Kim T, Hori M, Onishi H, Nakamoto A, Eguchi H, Nagano H, Wakasa K, Hatazawa J, Tomiyama N.
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [Abstract] [Full Text] [Related]

  • 25. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
    Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S.
    Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
    [Abstract] [Full Text] [Related]

  • 26. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, Glielmi C, Friedman KP.
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [Abstract] [Full Text] [Related]

  • 27. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, Kurhanewicz J, Manferrari F, Brunocilla E, Tonon C, Monetti N, Castellucci P, Fanti S, Coe M, Grigioni WF, Martorana G, Canini R, Barbiroli B.
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [Abstract] [Full Text] [Related]

  • 28. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
    Beer AJ, Eiber M, Souvatzoglou M, Holzapfel K, Ganter C, Weirich G, Maurer T, Kübler H, Wester HJ, Gaa J, Krause BJ.
    Mol Imaging Biol; 2011 Apr; 13(2):352-61. PubMed ID: 20490932
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
    Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, Korkola P, Soimakallio S, Eskola H, Dastidar P.
    NMR Biomed; 2011 Dec; 24(10):1181-90. PubMed ID: 21387451
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C, Chen M, Wang J, Wang X, Zhang W, Zhang C.
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
    Wetter A, Nensa F, Lipponer C, Guberina N, Olbricht T, Schenck M, Schlosser TW, Gratz M, Lauenstein TC.
    Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
    [Abstract] [Full Text] [Related]

  • 40. How good is post-biopsy multiparametric magnetic resonance imaging in detecting and characterising the index lesion of localised prostate cancer?
    Engelhard K, Labanaris AP, Bogner K, Lübke L, Dworak O, Kühn R.
    Scand J Urol; 2014 Dec; 48(6):499-505. PubMed ID: 24754780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.